First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study

The optimal targeted therapy sequence in patients of RAS wild-type left-sided metastatic colorectal cancer (mCRC) remains controversial, and few studies focus on the impact of first-line targeted agents on second-line ones. We enrolled 101 left-sided mCRC patients with RAS wild-type status, of which...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Liu, Shousheng, Jiang, Chang, Yang, Lin, Huang, Jinsheng, Peng, Roujun, Wang, Xiaopai, He, Wenzhuo, Bai, Long, Zhou, Yixin, Zhang, Bei, Xia, Liangping
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378223/
https://ncbi.nlm.nih.gov/pubmed/32704062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-69230-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados